MAJOR CANCER SUSCEPTIBILITY GENES
• Increasingly important in disease progression
– Estimate BRCA2 carrier has a 25-42% chance of PCA death (Clarke, Fleshner et al, in
press)
– 38% of carriers have no family history (Kim et al 2019)
• Confers systemic therapy sensitivity